Search
for
Sort by
Research 211–240 of 1000+
- B/N-doped carbon nano-onions as nanocarriers for targeted breast cancer therapy
- Cutaneous epitheliotropic T‐cell lymphoma in a sugar glider (<i>Petaurus breviceps</i>)
- Chitosan-based nanoformulations for alopecia treatment
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology
- Analysis and clinical determinants of post-COVID-19 syndrome in the Lombardy region: evidence from a longitudinal cohort study
- Identification of Familial Infections Using Multilocus Microsatellite Typing in Tinea Corporis due to <i>Microsporum canis</i>
- Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment
- Baricitinib Treatment Increases Eyebrow and Eyelash Regrowth Up to 52 Weeks
- Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata
- Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2
- Sessualità e sindrome dell’ovaio policistico
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- A case of cicatricial alopecia associated with pemphigus: a case report
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Dermatologic adverse effect of subcutaneous furosemide administration in a cat
- Seborrheic Dermatitis as a Potential Trigger of Central Centrifugal Cicatricial Alopecia: A Review of Literature
- Iperandrogenismo della donna in menopausa
- Issue Information
- 704 Is intrafollicular autophagy an essential mechanism that permits human hair follicles to remain in prolonged anagen in vivo?
- A Comparison of Reticle Size to Determine Follicular Unit Density in Hair Restoration
- The Role of Labrasol® in the Enhancement of the Cutaneous Bioavailability of Minoxidil in Phospholipid Vesicles
- Preliminary Studies for ^|^ldquo;Biomedical Analysis of Human Hair Exposed to Long-term Space Flight (Hair)^|^rdquo; Project: An Analysis of Trace Elements in the Hair
- Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy
- Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
- Organ-Level Quorum Sensing Directs Regeneration in Hair Stem Cell Populations